These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37776915)

  • 1. Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.
    Rogers L; Jesenak M; Bjermer L; Hanania NA; Seys SF; Diamant Z
    Respir Med; 2023 Nov; 218():107414. PubMed ID: 37776915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers.
    Santus P; Saad M; Damiani G; Patella V; Radovanovic D
    Pharmacol Res; 2019 Aug; 146():104296. PubMed ID: 31173886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological treatments for severe asthma.
    Assaf SM; Hanania NA
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):379-386. PubMed ID: 31169594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
    Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
    MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to compare the efficacy of biologic agents in asthma.
    Viswanathan RK; Busse WW
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):137-149. PubMed ID: 32387169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics in asthma--the next step toward personalized treatment.
    Darveaux J; Busse WW
    J Allergy Clin Immunol Pract; 2015; 3(2):152-60; quiz 161. PubMed ID: 25754716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe T2-high asthma in the biologics era: European experts' opinion.
    Pavord I; Bahmer T; Braido F; Cosío BG; Humbert M; Idzko M; Adamek L
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 severe asthma: pathophysiology and treatment with biologics.
    Pelaia C; Melhorn J; Hinks TS; Couillard S; Vatrella A; Pelaia G; Pavord ID
    Expert Rev Respir Med; 2024 Jul; 18(7):485-498. PubMed ID: 38994712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision care in the treatment of pediatric asthma.
    Mahmood L; Keskin S; Jefferson AA
    Curr Opin Pediatr; 2024 Jun; 36(3):304-309. PubMed ID: 38411592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of biologics in asthma endotypes.
    Wangberg H; Woessner K
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):79-85. PubMed ID: 33306486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies and opportunities in severe asthma.
    Humbert M; Busse W; Hanania NA
    Curr Opin Pulm Med; 2018 Jan; 24(1):83-93. PubMed ID: 29059087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pragmatic Clinical Perspective on Biologics for Severe Refractory Type 2 Asthma.
    Chan R; RuiWen Kuo C; Lipworth B
    J Allergy Clin Immunol Pract; 2020; 8(10):3363-3370. PubMed ID: 32673880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics for severe asthma and beyond.
    Mümmler C; Milger K
    Pharmacol Ther; 2023 Dec; 252():108551. PubMed ID: 37907197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [THE OVERLAPPING ELIGIBILITY FOR BIOLOGICS IN PATIENTS WITH SEVERE ASTHMA AND PHENOTYPES].
    Ito A; Miyoshi S; Toyota H; Suzuki Y; Uehara Y; Hattori S; Takeshita Y; Sakasegawa H; Kuramochi M; Kobayashi K; Sugimoto N; Nagase H
    Arerugi; 2022; 71(3):210-220. PubMed ID: 35569943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized Medicine in Severe Asthma: From Biomarkers to Biologics.
    Chen CY; Wu KH; Guo BC; Lin WY; Chang YJ; Wei CW; Lin MJ; Wu HP
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologics for severe asthma-Which, when and why?
    Shah PA; Brightling C
    Respirology; 2023 Aug; 28(8):709-721. PubMed ID: 37222237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologics in the treatment of asthma in children and adolescents.
    Bacharier LB; Jackson DJ
    J Allergy Clin Immunol; 2023 Mar; 151(3):581-589. PubMed ID: 36702649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-life studies of biologics used in asthma patients: key differences and similarities to trials.
    Heffler E; Paoletti G; Giorgis V; Puggioni F; Racca F; Del Giacco S; Bagnasco D; Caruso C; Brussino L; Rolla G; Canonica GW
    Expert Rev Clin Immunol; 2019 Sep; 15(9):951-958. PubMed ID: 31389304
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical use of biologics for asthma treatment by allergy specialists: A questionnaire survey.
    Kuruvilla M; Ariue B; Oppenheimer JJ; Singh U; Bernstein JA
    Ann Allergy Asthma Immunol; 2020 Oct; 125(4):433-439. PubMed ID: 32629016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of biologics in personalized asthma care.
    Watchorn D; Holguin F
    Expert Rev Clin Immunol; 2021 Dec; 17(12):1301-1309. PubMed ID: 34767743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.